By the HSAC TEAM Healthspan Action Coalition (HSAC) is sponsoring The Livelong Summit™ to bring you an exclusive 2-day event featuring some of the greatest minds in medicine and longevity science. Because so many medical professionals have already signed up, we’ve...

By April Wendling, University of Illinois at Urbana-Champaign - Phys.org - CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and...

By U. Rochester-URMC -  Futuirity - The American Red Cross is experiencing the most critical blood shortage in 20 years. Blood shortages are all too common, but they’re occurring more frequently now than ever before. Contact the Red Cross to find local blood drives...

Ben Andrew Henry - The Scientist - While studying a rare genetic disease, researchers discovered a signaling pathway linked to the efficiency of reprogramming somatic cells into stem cells. Thanks to a chance discovery, researchers have found a more efficient way to...

By Joseph Keenan - Fierce Pharma - Robotics specialist Multiply Labs and Thermo Fisher Scientific inked a deal to expand their partnership to further automate the cell therapy production process. The two companies will integrate Multiply Lab's robotic technology and...

By Tu Wien News A new approach to producing artificial tissue has been developed at TU Wien: Cells are grown in microstructures created in a 3D printer. Is it possible to grow tissue in the laboratory, for example to replace injured cartilage? At TU Wien (Vienna), an...

By Andrea Park -Fierce Biotech - For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial intelligence-powered...

by Technology Networks - Biopharma News - Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute...

By Dr Naomi Phillips - Progress.org - Viral genetic material, integrated into our DNA millions of years ago, has an essential role in a key early stage in embryo development. Using a mouse model, scientists in Spain have shown that endogenous retroviruses, part of the...

By Kyle LaHucik - Endpoints News Neurona Therapeutics has gathered $120 million in what is expected to be its last private financing round to wrap up an open-label study this year and move its epilepsy cell therapy into a randomized Phase II in 2025, CEO and...

by Marni Ellery - Berkley Engineering - Nobel laureate details new applications at Kuh Distinguished Lecture. Jennifer Doudna, Nobel laureate and Li Ka Shing Chancellor’s Chair and Professor in the Departments of Chemistry and of Molecular and Cell Biology, presented...

By Edvard Pettersson - Courthouse News Service - The FDA asked the Ninth Circuit to follow their colleagues on the 11th Circuit and find that novel stem cell procedures are not exempt from the agency's oversight. PASADENA, Calif. (CN) — The U.S. Food and Drug...